Loading data for NAMSW — first visit, this takes a few seconds.
NewAmsterdam Pharma N.V. (NAMSW)
NasdaqGM: NAMSW
· リアルタイム株価 · USD
16.00
+0.00 (0.00%)
終値時点： Aug 18, 2026, 6:21 PM
NewAmsterdam Pharma N.V. (NAMSW) Stock Price, Analysis & Data
0.00% (1D)
データがありません
NAMSWについて
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is ...
企業情報の全文